Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Medicinal Chemicals & Botanical Products

Standard Industrial Classification: SIC 2833

Industry Insider Sentiment Analysis

The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2018-07-04 02:52 2018-07-02 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $115.24 40,000 $4,609,544 10,495,614
2018-07-04 02:53 2018-07-02 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $115.24 40,000 $4,609,544 10,495,614
2018-06-26 23:53 2014-04-10 NPHC Nutra Pharma Corporation DEITSCH RIK J Director, Officer, 10% owner BUY $0.01 31,250,000 $275,000 43,298,859
2018-06-19 23:09 2018-06-15 MRMD MARIMED INC. KIDRIN THOMAS Director SELL $3.56 32,994 $117,459 1,763,673
2018-06-06 04:20 2018-06-01 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $115.36 44,285 $5,108,580 10,535,614
2018-06-06 04:18 2018-06-01 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $115.36 44,285 $5,108,580 10,535,614
2018-06-06 04:15 2017-12-06 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director BUY $70.62 19,117 $1,349,964 10,921,609
2018-06-06 04:15 2017-12-01 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $112.61 360,827 $40,632,728 10,579,899
2018-06-01 04:49 2017-12-06 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner BUY $70.62 19,117 $1,349,964 10,921,609
2018-06-01 04:49 2017-12-01 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $112.61 360,827 $40,632,728 10,579,899
2018-05-31 04:45 2018-05-25 FTLF FITLIFE BRANDS, INC. Dayton Judd Director, Officer, 10% owner BUY $0.37 44,400 $16,388 44,400
2018-05-26 03:28 2018-05-23 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $115.23 104,144 $12,000,846 10,921,609
2018-05-26 03:30 2018-05-23 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $115.23 104,144 $12,000,846 10,921,609
2018-05-23 01:46 2018-05-18 CDXC Niagen Bioscience, Inc. FARR KEVIN M Officer BUY $3.83 5,000 $19,150 5,000
2018-05-22 01:04 2018-05-17 NAII NATURAL ALTERNATIVES INTERNATIONAL INC Dunn Alan G Director SELL $10.68 9,000 $96,120 39,328
2018-05-21 22:35 2018-05-17 NAII NATURAL ALTERNATIVES INTERNATIONAL INC LANE ALAN J Director SELL $10.55 1,000 $10,550 48,328
2018-05-21 13:04 2018-05-18 NAII NATURAL ALTERNATIVES INTERNATIONAL INC WELDON LEE G Director SELL $10.58 7,000 $74,060 73,961
2018-05-18 23:47 2018-05-16 USNA USANA HEALTH SCIENCES INC Mulham David Mulham Officer OPT+S $113.03 14,733 $1,665,262 0
2018-05-18 01:31 2018-05-17 CDXC Niagen Bioscience, Inc. Friedman Mark J Officer BUY $3.60 3,000 $10,800 3,000
2018-05-16 23:59 2018-05-15 CDXC Niagen Bioscience, Inc. Jaksch Frank L Jr Director, Officer BUY $3.59 9,800 $35,163 211,357
2018-05-16 19:10 2018-05-15 CDXC Niagen Bioscience, Inc. Fried Robert N Director, Officer BUY $3.63 10,000 $36,300 926,574
2018-05-03 23:30 2018-05-01 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $105.96 40,000 $4,238,492 11,162,153
2018-05-03 23:29 2018-05-02 USNA USANA HEALTH SCIENCES INC IIEKKING G DOUG Officer OPT+S $105.54 510 $53,824 0
2018-05-03 23:30 2018-05-01 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $105.96 40,000 $4,238,492 11,162,153
2018-04-05 00:51 2018-04-03 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $86.23 40,000 $3,449,196 11,214,053
2018-04-05 00:51 2018-04-03 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $86.23 40,000 $3,449,196 11,214,053
2018-04-02 23:39 2018-03-29 CDXC Niagen Bioscience, Inc. Jaksch Frank L Jr Director, Officer OPT+S $4.60 474 $2,180 201,557
2018-03-30 00:03 2018-03-27 CDXC Niagen Bioscience, Inc. Jaksch Frank L Jr Director, Officer OPT+S $4.60 24,578 $113,059 201,557
2018-03-16 01:07 2018-03-13 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $80.67 40,000 $3,226,840 11,254,053
2018-03-16 01:07 2018-03-13 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $80.67 40,000 $3,226,840 11,254,053
2018-03-13 01:31 2018-03-08 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $81.10 228,000 $18,491,758 11,294,053
2018-03-13 01:31 2018-03-08 USNA USANA HEALTH SCIENCES INC Jones Paul A. Officer OPT+S $81.00 10,696 $866,376 0
2018-03-13 01:31 2018-03-08 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $81.10 228,000 $18,491,758 11,294,053
2018-03-08 02:08 2018-03-07 USNA USANA HEALTH SCIENCES INC IIEKKING G DOUG Officer OPT+S $81.05 2,423 $196,389 0
2018-03-06 04:18 2018-03-01 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $76.03 40,000 $3,041,280 11,522,053
2018-03-06 04:18 2018-03-01 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $76.03 40,000 $3,041,280 11,522,053
2018-02-17 01:59 2018-02-14 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $76.01 53,372 $4,056,747 11,562,053
2018-02-17 01:58 2018-02-14 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $76.01 53,372 $4,056,747 11,562,053
2018-02-16 02:31 2018-02-15 USNA USANA HEALTH SCIENCES INC Noot Walter Officer OPT+S $77.00 3,075 $236,775 0
2018-02-14 02:57 2018-02-09 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $75.39 28,405 $2,141,408 11,615,425
2018-02-14 02:57 2018-02-09 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $75.39 28,405 $2,141,408 11,615,425
2018-02-07 03:37 2018-02-02 USNA USANA HEALTH SCIENCES INC Gull Global Ltd 10% owner SELL $71.51 38,223 $2,733,453 11,643,830
2018-02-07 03:37 2018-02-02 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $71.51 38,223 $2,733,453 11,643,830
2018-02-02 00:54 2018-01-30 MRMD MARIMED INC. KIDRIN THOMAS Director SELL $1.22 300,000 $365,010 1,796,667
2018-01-13 00:56 2018-01-10 CDXC Niagen Bioscience, Inc. Jaksch Frank L Jr Director, Officer OPT+S $6.52 28,379 $184,906 201,557
2018-01-11 01:31 2018-01-08 AMMJ American Cannabis Company Inc. Hollister Corey James Ariel 10% owner SELL $1.27 66,000 $83,959 11,581,385
2018-01-05 23:19 2018-01-03 AMMJ American Cannabis Company Inc. Hollister Corey James Ariel 10% owner SELL $1.40 217,269 $304,676 11,647,385
2018-01-03 00:01 2017-12-28 AMMJ American Cannabis Company Inc. Smith Ellis Lamar Director, Officer, 10% owner SELL $1.17 400,000 $469,600 11,816,741
2018-01-02 18:10 2017-12-29 MTEX MANNATECH INC TOTH ROBERT Director BUY $15.00 2,000 $29,990 59,568
2017-12-27 20:51 2017-12-27 MTEX MANNATECH INC JOBE LARRY A Director BUY $14.70 1,500 $22,050 55,000
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Medicinal Chemicals & Botanical Products

Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.